OncoTherapy Science, Inc. (FRA:30O)

Germany · Delayed Price · Currency is EUR

0.0965

-0.0005 (-0.52%)

Last updated: Dec 2, 2025, 8:05 AM CET

Revenue by Product

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2003 - 2019
Cancer Precision Medical Services	747.06M	Log In	Log In	Log In	Log In	Upgrade
Cancer Precision Medical Services Growth	22.53%	Log In	Log In	Log In	Log In	Upgrade
Research and Development of Pharmaceutical Products and Related Business	2.99M	Log In	Log In	Log In	Log In	Upgrade
Research and Development of Pharmaceutical Products and Related Business Growth	600.47%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2003 - 2019
Japan	750.05M	Log In	Log In	Log In	Log In	Upgrade
Japan Growth	22.93%	Log In	Log In	Log In	Log In	Upgrade